Back to Authors

Myers, Jeffrey L.

https://orcid.org/0000-0001-8247-3028

Mayo Clinic

University of Michigan

Citations 23

Bronchiolar Disorders
Ryu, Jay H. , Swensen, Stephen J., Myers, Jeffrey L. , Ryu, Jay H

American Journal of Respiratory and Critical Care Medicine | November 25, 2003 | Volume: 168 | Issue: 11 | Pages: 1277-1292

10.1164/rccm.200301-053so Get It

Abstract Bronchiolar abnormalities are relatively common and occur in a variety of clinical settings. Various histopathologic patterns of bronchiolar injury have been described and have led to confusing nomenclature with redundant and overlapping terms. Some histopathologic patterns of bronchiolar disease may be relatively unique to a specific clinical context but others are nonspecific with respect to either etiology or pathogenesis. Herein, we present a scheme separating (1) those disorders in which the bronchiolar disease is the predominant abnormality (primary bronchiolar disorders) from (2) parenchymal disorders with prominent bronchiolar involvement and (3) bronchiolar involvement in large airway diseases. Primary bronchiolar disorders include constrictive bronchiolitis (obliterative bronchiolitis, bronchiolitis obliterans), acute bronchiolitis, diffuse panbronchiolitis, respiratory bronchiolitis, mineral dust airway disease, follicular bronchiolitis, and a few other rare variants. Prominent bronchiolar involvement may be seen in several interstitial lung diseases, including hypersensitivity pneumonitis, respiratory bronchiolitis–associated interstitial lung disease, cryptogenic organizing pneumonia (idiopathic bronchiolitis obliterans organizing pneumonia), and pulmonary Langerhans' cell histiocytosis. Large airway diseases that commonly involve bronchioles include bronchiectasis, asthma, and chronic obstructive pulmonary disease. The clinical relevance of a bronchiolar lesion is best determined by identifying the underlying histopathologic pattern and assessing the correlative clinico–physiologic–radiologic context.
Ventilator-induced Cell Wounding and Repair in the Intact Lung
Lee, Jae Ho , Doerr, Clinton H., Berríos, Jorge, Hubmayr, Rolf D., Gajic, Ognjen , Myers, Jeffrey L.

American Journal of Respiratory and Critical Care Medicine | April 8, 2003 | Volume: 167 | Issue: 8 | Pages: 1057-1063

10.1164/rccm.200208-889oc Get It

Abstract We tested the hypothesis that cells of ventilator-injured lungs are subject to reversible plasma membrane stress failure. Rat lungs were perfused with the membrane impermeable fluorescent marker propidium iodide and randomized to one of four ventilation strategies. Subpleural lung regions were imaged with confocal microscopy, and cell injury was quantified as the number of propidium iodide–positive cells per alveolus. The number of injured cells was significantly greater in lungs ventilated with large tidal volumes and zero end-expiratory pressure than in lungs ventilated with small tidal volumes and positive end-expiratory pressure (p < 0.01). Cell injury correlated with lung weight gain, change in dynamic compliance, and histologic injury scores. In a second set of experiments, lungs were mechanically ventilated for 30 minutes at high tidal volume settings, whereas propidium iodide was perfused either during or after injurious ventilation. Labeling after removal of injurious stress revealed significantly fewer injured cells (0.25 ± 0.09 to 0.08 ± 0.08, p < 0.01). We conclude that cells of ventilator-injured lungs are subject to reversible plasma membrane stress failure.
Pulmonary Langerhans Cell Histiocytosis: What Was the Question?
Aubry, Marie-Christine, Myers, Jeffrey L.

American Journal of Respiratory and Critical Care Medicine | November 25, 2002 | Volume: 166 | Issue: 11 | Pages: 1419-1421

10.1164/rccm.2209005 Get It